B of A Securities Maintains Buy on Apple, Lowers Price Target to $370
B of A Securities analyst Wamsi Mohan maintains Apple (NASDAQ:AAPL) with a Buy and lowers the price target from $380 to $370.
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
B of A Securities analyst Wamsi Mohan maintains Apple (NASDAQ:AAPL) with a Buy and lowers the price target from $380 to $370.
Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will present a poster at the American Association for
B of A Securities analyst Arnaud Lehmann maintains Sunbelt Rentals Holdings (NYSE:SUNB) with a Underperform and raises the price target from $62 to $71.
Filed: 2026-09-10 AccNo: 0001193125-26-387237 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
-SEC Filing
Filed: 2026-09-10 AccNo: 0001298946-26-000041 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
MasterCraft Boat Hldgs (NASDAQ:MCFT) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.64 by 4.69 percent. This is a 67.5 percent increase over earnings of $0.40 per share
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 100 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $19.862 million in
Filed: 2026-09-10 AccNo: 0001193125-26-387233 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-10 AccNo: 0001193125-26-387232 Size: 20 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Oracle reports earnings Sept. 10; analysts expect $1.74 EPS and $19.14B revenue. Its 1.24% yield requires ~$485K invested for $500 monthly.
B of A Securities analyst Lorraine Hutchinson maintains Signet Jewelers (NYSE:SIG) with a Neutral and raises the price target from $102 to $115.
Services to include Starshield and Starlink
Concorde International Group (NASDAQ:CIGL) is pleased to announce its subsidiary, Concorde Security, as the Official Security Partner of Hougang United Football Club (HGFC) for the 2026/27 season. Through this
AEO: -14% | Shares of American Eagle Outfitters are trading lower after the company reported Q2 financial results. The company disclosed that tariff refunds boosted its profit. COO: -16% | Cooper shares are trading
B of A Securities analyst Derek Hewett downgrades Crescent Capital BDC (NASDAQ:CCAP) from Buy to Neutral and lowers the price target from $13 to $10.25.
Filed: 2026-09-10 AccNo: 0001839341-26-000023 Size: 200 KB Item 7.01: Regulation FD Disclosure
Capital will support continued CNSide® commercial scale-up and developmentInitial tranche of funding provided at closing with future tranches linked to milestonesForecasted cash runway now into 2028HOUSTON, Sept. 10,
Under the agreement, the Company received initial funding at closing, with future tranches available upon achieving certain milestones. The financing is intended to support the scale-up of the Company’s proprietary
Reaffirms full-year 2026 guidanceProvides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5%Outlines strategic
David Smith, a current director on the Board, had acted as Interim Chief Financial Officer and principal financial officer during Mr. Knoblauch’s leave of absence. In connection with Mr. Knoblauch’s reinstatement, Mr.
B of A Securities analyst Craig Bijou downgrades Cooper Companies (NASDAQ:COO) from Buy to Neutral and lowers the price target from $80 to $65.
Tenable also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $65.0
BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology company developing
Labcorp Holdings (NYSE:LH) affirms FY2026 Adj EPS guidance from $18.10-$18.55 to $18.10-$18.55 vs $18.01 analyst estimate. Affirms FY2026 sales outlook from $14.710 billion-$14.827 billion to $14.710 billion-$14.827
The collaboration is designed to remove two of the most persistent barriers facing emerging artists—securing high-quality visual content and earning meaningful exposure on mainstream radio. Through the partnership,
Filed: 2026-09-10 AccNo: 0001193125-26-387204 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits